Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
The portfolio for Mologic Ltd. currently features 1 pending office action in the Chemistry & Materials technology area. This matter is assigned to 1 distinct examiner, SIEFKE, SAMUEL P, who serves as the busiest examiner with 1 pending case. All current prosecution activity is situated within 1 distinct art unit.
Because the company's active cases are limited to 1 distinct art unit, the technical focus of the portfolio is highly concentrated. The interaction with SIEFKE, SAMUEL P is the sole determining factor for the resolution of the 1 pending office action. Practitioners should prioritize understanding the specific preferences of this examiner to ensure a favorable outcome.
With 1 distinct examiner overseeing the entire pending workload, there is no diversity in examination styles within the current Chemistry & Materials portfolio. The centralized nature of this prosecution means that the company's immediate patent success depends on this single active matter. Future growth may eventually require navigating additional distinct art units or examiners.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SIEFKE, SAMUEL P | 1 | 63.1% | +17.8% |
| KIRWIN, STEFANIE JOHANNA | 1 | 15.9% | +31.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17263449 | BACTERIAL VAGINOSIS DIAGNOSTIC | KIRWIN, STEFANIE JOHANNA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18015797 | LATERAL FLOW DEVICE | SIEFKE, SAMUEL P | — |
| 17263449 | BACTERIAL VAGINOSIS DIAGNOSTIC | KIRWIN, STEFANIE JOHANNA | — |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| 1677 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18015797 | LATERAL FLOW DEVICE | SIEFKE, SAMUEL P | 1758 | §102 | Non-Final OA | — | Pending | Jan 12, 2023 |
| 17263449 | BACTERIAL VAGINOSIS DIAGNOSTIC | KIRWIN, STEFANIE JOHANNA | 1677 | §103§112 | Final Rejection | — | Pending | Jan 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial